Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Center for Systems Biology, Department of Radiology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02114, USA.
Cell. 2021 Mar 4;184(5):1348-1361.e22. doi: 10.1016/j.cell.2021.01.049. Epub 2021 Feb 25.
Clonal hematopoiesis, a condition in which individual hematopoietic stem cell clones generate a disproportionate fraction of blood leukocytes, correlates with higher risk for cardiovascular disease. The mechanisms behind this association are incompletely understood. Here, we show that hematopoietic stem cell division rates are increased in mice and humans with atherosclerosis. Mathematical analysis demonstrates that increased stem cell proliferation expedites somatic evolution and expansion of clones with driver mutations. The experimentally determined division rate elevation in atherosclerosis patients is sufficient to produce a 3.5-fold increased risk of clonal hematopoiesis by age 70. We confirm the accuracy of our theoretical framework in mouse models of atherosclerosis and sleep fragmentation by showing that expansion of competitively transplanted Tet2 cells is accelerated under conditions of chronically elevated hematopoietic activity. Hence, increased hematopoietic stem cell proliferation is an important factor contributing to the association between cardiovascular disease and clonal hematopoiesis.
造血细胞克隆性,一种个体造血干细胞克隆生成不成比例的血液白细胞的情况,与心血管疾病风险增加相关。这种关联的背后机制尚未完全了解。在这里,我们表明动脉粥样硬化的小鼠和人类的造血干细胞分裂率增加。数学分析表明,干细胞增殖的增加加速了具有驱动突变的克隆的体细胞进化和扩张。在动脉粥样硬化患者中实验确定的分裂率升高足以产生 3.5 倍的克隆性造血风险,到 70 岁。我们通过显示在慢性升高的造血活性条件下竞争移植的 Tet2 细胞的扩张加速来确认我们在动脉粥样硬化和睡眠片段化的小鼠模型中的理论框架的准确性。因此,造血干细胞增殖增加是导致心血管疾病与克隆性造血之间关联的重要因素。